Study Title
A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
Protocol ID
ARST2031
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Newly diagnosed
Location
NSW, VIC, WA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Perth Children's Hospital
John Hunter Children's Hospital
The Children's Hospital at Westmead
Royal Children's Hospital
John Hunter Children's Hospital
The Children's Hospital at Westmead
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 50 Years
International registry ID's
NCT04994132
| Study Title | A Randomized Phase 3 Trial of Vinorelbine Dactinomycin and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS) |
|---|---|
| Protocol ID | ARST2031 |
| Disease (Sub Disease) | Rhabdomyosarcoma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW / VIC / WA |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT04994132 |
| Trial Status | Open |
| Trial Open Date | 12/09/2023 |
| Sites | Perth Children's Hospital / John Hunter Children's Hospital/ The Children's Hospital at Westmead/ Royal Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 50 Years |
| International registry ID's | NCT04994132 |